D.E. Shaw & Co’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-78,218
Closed -$1.06M 4453
2025
Q1
$1.06M Buy
+78,218
New +$1.5M ﹤0.01% 3050
2024
Q3
Sell
-29,721
Closed -$690K 4624
2024
Q2
$690K Sell
29,721
-86,544
-74% -$1.66M ﹤0.01% 3428
2024
Q1
$2.39M Buy
+116,265
New +$2.19M ﹤0.01% 2488
2023
Q2
Sell
-44,336
Closed -$1.02M 4322
2023
Q1
$1.02M Sell
44,336
-90,091
-67% -$2.48M ﹤0.01% 3149
2022
Q4
$3.74M Buy
+134,427
New +$4M 0.01% 2365
2022
Q3
Sell
-86,113
Closed -$2.53M 5272
2022
Q2
$2.53M Buy
86,113
+79,865
+1,278% +$2.09M ﹤0.01% 2857
2022
Q1
$201K Sell
6,248
-988
-14% -$34K ﹤0.01% 4864
2021
Q4
$323K Sell
7,236
-38,177
-84% -$1.81M ﹤0.01% 4646
2021
Q3
$2.29M Sell
45,413
-38,172
-46% -$2.15M ﹤0.01% 2907
2021
Q2
$6.56M Sell
83,585
-122,577
-59% -$7.58M 0.01% 1825
2021
Q1
$11.8M Buy
206,162
+126,802
+160% +$8.49M 0.01% 1252
2020
Q4
$6.65M Sell
79,360
-65,658
-45% -$3.97M 0.01% 1660
2020
Q3
$5.2M Buy
+145,018
New +$4.37M 0.01% 1659
2019
Q3
Sell
-102,274
Closed -$2.12M 3860
2019
Q2
$2.12M Buy
+102,274
New +$2.29M ﹤0.01% 2210

Other funds holding DNLI